Concerto Biosciences CEO Cheri Ackerman (L) and CSO Jared Kehe

'Rule­book of mi­cro­bial ecol­o­gy': Pi­anists launch Con­cer­to to treat eczema, pro­tect crops and get rid of BO

The mi­cro­bio­me world, at least in drug R&D, has had some hic­cups this year, with Flag­ship’s Kalei­do Bio­sciences shut­ting down and DermBiont piv­ot­ing away from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.